Skip to main content

Cerus Corp

CERS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001020214

In the last 90 days, Cerus Corp insiders filed 0 open-market purchases and 6 sales; 185 institutions reported holding it in 13F filings for Q2 2026, worth $437.9M in total; ARK Invest is the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Cerus Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
6 filings
4 insiders, $737.5K in total
Insiders trading
4
Net value
−$737.5K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Cerus Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Cerus Corp
NameTitleLast reported holdingLast filingFilings, past year
Menard ChrystalChief Legal Officer936,657Aug 17, 20267
Jayaraman Vivek KChief Executive Officer2,232,211Jul 20, 20267
Green Kevin DennisChief Financial Officer1,062,188Jul 2, 20265
Greenman William MarinerPresident and CEO5,053,036Jul 2, 20264
Bjerkholt EricDirector261,679Jun 11, 20262
Nachtsheim Jami KDirector268,362Jun 2, 20261
Witney FrankDirector340,059Jun 2, 20261
Lucena AnnDirector232,284Jun 2, 20261
Shan HuaDirector192,386Jun 2, 20261
Gregory Dean A.Director146,725Jun 2, 20261
Benjamin Richard JChief Medical Officer777,361Mar 16, 20263
Swisher Daniel N JRDirector207,045Jun 4, 20250
Moore Timothy L.Director205,073Jun 4, 20250
Schulze GailDirector163,420Jun 6, 20240
Corash Laurence MChief Scientific Officer2,339,740Mar 14, 20240
Moore CarolSVP Reg. & Quality490,623Mar 14, 20240

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 17, 2026 (view filing)8:18 PM ETAug 17Same dayMenard ChrystalChief Legal OfficerSSale−30.0K$2.98−$89.5K−3.1%936.7K after10b5-1
Jul 20, 2026 (view filing)5:03 PM ETJul 164 daysJayaraman Vivek KChief Executive OfficerSSale−16.7K$3.16−$52.7K−0.7%2.23M after10b5-1
Jul 2, 2026 (view filing)7:19 PM ETJun 302 daysGreen Kevin DennisChief Financial OfficerSSale−33.7K$2.94−$99.1K−3.1%1.06M after10b5-1
Jul 2, 2026 (view filing)7:18 PM ETJun 302 daysJayaraman Vivek KChief Operating OfficerSSale−42.4K$2.94−$124.7K−2.4%1.69M after10b5-1
Jul 2, 2026 (view filing)7:15 PM ETJun 302 daysMenard ChrystalChief Legal OfficerSSale−24.3K$2.94−$71.6K−2.5%966.7K after10b5-1
Jul 2, 2026 (view filing)7:13 PM ETJun 302 daysGreenman William MarinerPresident and CEOSSale−101.9K$2.94−$299.9K−2.0%5.05M after10b5-1
Jun 11, 2026 (view filing)Jun 92 daysBjerkholt EricDirectorSSale−20.5K$2.60−$53.2K−7.2%261.7K after
Jun 2, 2026 (view filing)May 294 daysJayaraman Vivek KChief Operating OfficerSSale−16.7K$3.00−$50.0K−1.0%1.66M after10b5-1
May 5, 2026 (view filing)May 14 daysJayaraman Vivek KChief Operating OfficerSSale−16.7K$3.00−$50.0K−1.0%1.67M after10b5-1
Mar 16, 2026 (view filing)Mar 124 daysJayaraman Vivek KChief Operating OfficerSSale−165.2K$1.66−$274.2K−8.6%1.75M after10b5-1
Mar 16, 2026 (view filing)Mar 12, 2025369 daysLateMenard ChrystalChief Legal OfficerSSale−113.0K$1.66−$187.6K−10.7%946.1K after10b5-1
Mar 16, 2026 (view filing)Mar 124 daysGreen Kevin DennisChief Financial OfficerSSale−127.5K$1.66−$211.7K−10.9%1.04M after10b5-1
Mar 16, 2026 (view filing)Mar 124 daysGreenman William MarinerPresident and CEOSSale−447.8K$1.66−$743.3K−8.2%5.00M after10b5-1
Mar 16, 2026 (view filing)Mar 124 daysBenjamin Richard JChief Medical OfficerSSale−101.7K$1.66−$168.9K−11.6%777.4K after10b5-1
Mar 10, 2026 (view filing)Mar 5-95 daysBenjamin Richard JChief Medical OfficerSSale−125.9K$1.99−$250.9K−12.5%879.1K afterAmended3 lots10b5-1
Mar 9, 2026 (view filing)Mar 63 daysJayaraman Vivek KChief Operating OfficerSSale−34.1K$2.01−$68.5K−1.8%1.91M after10b5-1
Mar 9, 2026 (view filing)Mar 63 daysMenard ChrystalChief Legal OfficerSSale−30.8K$2.01−$62.0K−2.8%1.06M after10b5-1
Mar 9, 2026 (view filing)Mar 5-64 daysGreen Kevin DennisChief Financial OfficerSSale−83.0K$2.04−$169.6K−6.6%1.17M after2 lots10b5-1
Mar 9, 2026 (view filing)Mar 63 daysGreenman William MarinerPresident and CEOSSale−78.2K$2.01−$157.2K−1.4%5.45M after10b5-1
Nov 26, 2025 (view filing)Nov 242 daysMenard ChrystalChief Legal OfficerSSale−55.0K$1.70−$93.5K−7.0%728.3K after10b5-1
Aug 25, 2025 (view filing)Aug 25Same dayGregory Dean A.DirectorPPurchase+25.0K$1.25+$31.3K+40.5%86.7K after
Mar 17, 2025 (view filing)Mar 13-144 daysMenard ChrystalChief Legal OfficerSSale−49.0K$1.45−$71.1K−5.9%783.3K after2 lots10b5-1
Mar 17, 2025 (view filing)Mar 13-144 daysJayaraman Vivek KChief Operating OfficerSSale−76.0K$1.45−$110.2K−5.0%1.43M after2 lots10b5-1
Mar 17, 2025 (view filing)Mar 13-144 daysGreenman William MarinerPresident and CEOSSale−193.9K$1.45−$281.2K−4.5%4.12M after2 lots10b5-1
Mar 17, 2025 (view filing)Mar 13-144 daysGreen Kevin DennisChief Financial OfficerSSale−59.9K$1.45−$86.8K−6.4%875.9K after2 lots10b5-1
Mar 17, 2025 (view filing)Mar 13-144 daysBenjamin Richard JChief Medical OfficerSSale−49.0K$1.45−$71.1K−6.7%685.8K after2 lots10b5-1
Mar 10, 2025 (view filing)Mar 73 daysMenard ChrystalChief Legal OfficerSSale−27.5K$1.50−$41.2K−3.2%832.3K after10b5-1
Mar 10, 2025 (view filing)Mar 73 daysJayaraman Vivek KChief Operating OfficerSSale−34.0K$1.50−$51.0K−2.2%1.51M after10b5-1
Mar 10, 2025 (view filing)Mar 73 daysGreenman William MarinerPresident and CEOSSale−61.0K$1.50−$91.5K−1.4%4.31M after10b5-1
Mar 10, 2025 (view filing)Mar 73 daysGreen Kevin DennisChief Financial OfficerSSale−31.1K$1.50−$46.7K−3.2%935.8K after10b5-1
Mar 10, 2025 (view filing)Mar 73 daysBenjamin Richard JChief Medical OfficerSSale−26.1K$1.50−$39.2K−3.4%734.8K after10b5-1
Mar 5, 2025 (view filing)Mar 41 dayMenard ChrystalChief Legal OfficerSSale−66.3K$1.59−$105.2K−14.1%405.2K after2 lots10b5-1
Mar 5, 2025 (view filing)Mar 41 dayJayaraman Vivek KChief Operating OfficerSSale−10.8K$1.55−$16.7K−1.2%905.8K after10b5-1
Mar 5, 2025 (view filing)Mar 41 dayGreenman William MarinerPresident and CEOSSale−23.0K$1.55−$35.7K−0.7%3.23M after10b5-1
Mar 5, 2025 (view filing)Mar 3-42 daysGreen Kevin DennisChief Financial OfficerSSale−69.0K$1.58−$108.8K−12.3%493.9K after2 lots10b5-1
Mar 5, 2025 (view filing)Mar 3-42 daysBenjamin Richard JChief Medical OfficerSSale−57.5K$1.58−$90.7K−12.7%394.4K after2 lots10b5-1
Jan 2, 2025 (view filing)Dec 13, 202420 daysLateGregory Dean A.DirectorPPurchase+1.73K$1.70+$2.93K+2.9%61.7K after10b5-1
Dec 16, 2024 (view filing)Dec 124 daysBjerkholt EricDirectorSSale−20.0K$1.79−$35.8K−11.0%162.1K after
Dec 16, 2024 (view filing)Dec 16Same dayMenard ChrystalChief Legal OfficerSSale−16.7K$1.71−$28.5K−3.5%457.6K after10b5-1
Sep 5, 2024 (view filing)Sep 3-42 daysGreen Kevin DennisChief Financial OfficerSSale−82.7K$2.16−$178.6K−13.4%536.1K after2 lots10b5-1
Aug 19, 2024 (view filing)Aug 154 daysMenard ChrystalChief Legal OfficerSSale−16.7K$2.07−$34.5K−3.4%474.2K after10b5-1
Aug 7, 2024 (view filing)Aug 25 daysLateBenjamin Richard JChief Medical OfficerSSale−21.6K$2.50−$54.0K−4.7%438.0K after10b5-1
May 14, 2024 (view filing)May 131 dayShan HuaDirectorPPurchase+2.50K$1.99+$4.97K+8.4%32.4K after
May 13, 2024 (view filing)May 103 daysNachtsheim Jami KDirectorPPurchase+2.00K$1.79+$3.58K+1.9%108.4K after
May 10, 2024 (view filing)May 91 dayWitney FrankDirectorPPurchase+20.0K$1.89+$37.8K+12.5%180.1K after
May 9, 2024 (view filing)May 9Same daySwisher Daniel N JRDirectorPPurchase+2.50K$1.88+$4.70K+2.4%107.0K after
Mar 14, 2024 (view filing)Mar 13-141 dayGreen Kevin DennisChief Financial OfficerSSale−42.6K$1.99−$84.9K−6.4%618.8K after2 lots
Mar 14, 2024 (view filing)Mar 131 dayMoore CarolSVP Reg. & QualitySSale−20.6K$2.01−$41.5K−4.0%490.6K after2 lots
Mar 14, 2024 (view filing)Mar 13-141 dayMenard ChrystalChief Legal OfficerSSale−35.3K$2.01−$71.1K−6.7%490.9K after2 lots
Mar 14, 2024 (view filing)Mar 13-141 dayJayaraman Vivek KChief Operating OfficerSSale−53.0K$2.01−$106.9K−5.7%878.7K after2 lots